Establishment and verification of an osteoporosis risk model in patients with rheumatoid arthritis: a valuable new model

被引:5
作者
Yan, Xiaobin [1 ]
Xu, Zhenhong [1 ]
Li, Shilin [1 ]
Yan, Lisheng [3 ]
Lyu, Guorong [1 ,2 ]
Wang, Zecheng [1 ]
机构
[1] Fujian Med Univ, Dept Ultrasound, Affiliated Hosp 2, Quanzhou 362000, Peoples R China
[2] Quanzhou Med Coll, Dept Clin Med, Quanzhou 362000, Peoples R China
[3] Fujian Med Univ, Dept Radiol, Affiliated Hosp 2, Quanzhou 362000, Peoples R China
关键词
Rheumatoid arthritis; Osteoporosis; Prediction model; Model verification; 7-joint ultrasound score; BONE-MINERAL DENSITY; CITRULLINATED PROTEIN ANTIBODIES; EROSIONS; SCORE;
D O I
10.1007/s11657-020-00867-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To establish a model for osteoporosis risk in patients with rheumatoid arthritis and validate the model. A newly generated predictive model has been suggested to have good differentiation, calibration, and clinical validity and may be a useful clinical model for predicting osteoporosis in patients with rheumatoid arthritis. Purpose To establish a prediction model for osteoporosis risk in patients with rheumatoid arthritis and validate the model internally and externally. Methods A total of 270 patients with rheumatoid arthritis who underwent bone mineral density measurement at our hospital from June 2019 to June 2020 were enrolled in the study. The patients were divided into two groups according to their entry time: a training set containing the first 2/3 of the patients (n = 180) and a validation set containing the remaining 1/3 of the patients (n = 90). Binary logistic regression analysis was used to establish the regression models, and the concordance index (C-index), calibration plot, and decision curve analysis were used to evaluate the prediction model. Results Five variables, including age (X1), course of disease (X2), the disease activity score using 28 joint counts (DAS28) (X4), anti-cyclic citrullinated peptide antibody (CCP) (X7), and 7-joint ultrasonic bone erosion (X14), were selected to enter the model. The prediction model is Logit Y = - 12.647 + 0.133X1 + 0.011X2 + 0.754X4 + 0.001X7 + 0.605X14. The model had good differentiation; the C-index in the internal verification was 0.947 (95% CI is 0.932-0.977) and the C-index in the external verification was 0.946 (95% CI is 0.940-0.994). The calibration plot of the model showed excellent consistency between the prediction probability and actual probability. When > 0.483 was taken as the cutoff value for the diagnosis of osteoporosis, the sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and Jordan index of the model were 90.24%, 87.76%, 7.37, 0.11, and 78.00%, respectively. Conclusion A newly generated predictive model has been suggested to have good differentiation, calibration, and clinical validity and may be a useful clinical model for predicting osteoporosis in patients with rheumatoid arthritis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] FREQUENCY OF OSTEOPOROSIS AND ASSOCIATED RISK FACTORS IN MEXICAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rangel-Botello, A. N.
    Gallegos-Posada, A.
    Jasso-Avila, F.
    Ramos-Bello, D.
    Villa-Calderon, C.
    Martinez-Martinez, M. U.
    Abud-Mendoza, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1345 - 1345
  • [42] Role of 2-methoxyestradiol as inhibitor of arthritis and osteoporosis in a model of postmenopausal rheumatoid arthritis
    Stubelius, Alexandra
    Andreasson, Emil
    Karlsson, Anna
    Ohlsson, Claes
    Tivesten, Asa
    Islander, Ulrika
    Carlsten, Hans
    [J]. CLINICAL IMMUNOLOGY, 2011, 140 (01) : 37 - 46
  • [43] Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis
    J. Hwang
    E.-K. Lee
    J. K. Ahn
    H.-S. Cha
    E.-M. Koh
    J. Lee
    [J]. Osteoporosis International, 2017, 28 : 231 - 237
  • [44] Impact of glucocorticoids on the therapeutic efficacy of denosumab against osteoporosis in patients with rheumatoid arthritis
    Yang, Jiwon
    Park, Youngjae
    Lee, Jennifer Jooha
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Kim, Wan-Uk
    Park, Sung-Hwan
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2025, 17
  • [45] Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors
    Qiu, Jianjun
    Lu, Chunde
    Zhang, Lei
    Zhou, Xu
    Zou, Hanlin
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2685 - 2693
  • [46] Use of osteoporosis drugs in patients with recent-onset rheumatoid arthritis in Finland
    Hamalainen, H.
    Kautiainen, H.
    Pohjolainen, T.
    Virta, L.
    Jarvenpaa, S.
    Puolakka, K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : 835 - 838
  • [47] Relationship Between Physical Disability, Disease Activity and Osteoporosis in Patients With Rheumatoid Arthritis
    Ileana, Mihailov Claudia
    Nelutu, Mitroi Adrian
    [J]. ARCHIVES OF RHEUMATOLOGY, 2014, 29 (04): : 273 - 279
  • [48] Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors
    Jianjun Qiu
    Chunde Lu
    Lei Zhang
    Xu Zhou
    Hanlin Zou
    [J]. Clinical Rheumatology, 2022, 41 : 2685 - 2693
  • [49] Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis
    Hwang, J.
    Lee, E. -K.
    Ahn, J. K.
    Cha, H. -S.
    Koh, E. -M.
    Lee, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (01) : 231 - 237
  • [50] THE RISK OF OSTEOPOROTIC FRACTURES ACCORDING TO THE FRAX MODEL IN KOREAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Koh, J. H.
    Lee, J. H.
    Kang, J. Y.
    Suh, Y. S.
    Jung, S. M.
    Lee, J.
    Lee, J. Y.
    Park, S. -H.
    Kwok, S. -K.
    Kim, H-Y
    Kim, J. -M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 914 - 915